With Ultralute launched in Germany late last year, just wondering if people had any thoughts on the impact to this qtr's revenue. Hopefully there will be no 'timing issues' with EU sales like last qtr
Great little company with multiple products and large upside - good luck to all.
- Forums
- ASX - By Stock
- CYC
- Ultralute
CYC
cyclopharm limited
Add to My Watchlist
0.00%
!
$1.00

Ultralute
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.00 |
Change
0.000(0.00%) |
Mkt cap ! $110.0M |
Open | High | Low | Value | Volume |
$1.00 | $1.01 | 99.0¢ | $36.23K | 36.28K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 8150 | 99.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.00 | 6527 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 8150 | 0.995 |
4 | 23377 | 0.990 |
4 | 7967 | 0.980 |
1 | 500 | 0.975 |
3 | 41241 | 0.970 |
Price($) | Vol. | No. |
---|---|---|
1.000 | 6527 | 2 |
1.005 | 1355 | 1 |
1.010 | 580 | 1 |
1.015 | 210 | 1 |
1.025 | 210 | 1 |
Last trade - 12.57pm 18/06/2025 (20 minute delay) ? |
Featured News
CYC (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online